PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma.

Sahinli H., Akyürek N., Yılmaz M., Kandemir O., Duran A. O., Kulaçoğlu S., ...Daha Fazla

Indian journal of cancer, cilt.58, ss.561-566, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4103/ijc.ijc_459_19
  • Dergi Adı: Indian journal of cancer
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.561-566
  • Anahtar Kelimeler: Nasopharyngeal carcinoma, prognosis, programmed death ligand-1, TUMOR-INFILTRATING LYMPHOCYTES, PROGRAMMED DEATH LIGAND-1, GASTRIC-CANCER, DISTINCT EXPRESSION, T-CELLS, MICROENVIRONMENT, CHEMORADIOTHERAPY, RADIOTHERAPY, SURVIVAL, PHASE
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Programmed death-ligand 1 (PD-L1) has been determined as a reliable prognostic factor for various malignancies. In this study, we aimed to determine the prognostic effect of PD-L1 expression in tumor-infiltrating immune cells (TIICs) of nasopharyngeal carcinoma (NPC) patients.